BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, a drop of 83.3% from the March 31st total of 3,000 shares. Based on an average trading volume of 4,700 shares, the days-to-cover ratio is presently 0.1 days.

BioSyent Price Performance

OTCMKTS:BIOYF remained flat at $6.28 during mid-day trading on Friday. 20 shares of the company were exchanged, compared to its average volume of 2,903. The business has a 50 day simple moving average of $6.34 and a 200-day simple moving average of $6.28. BioSyent has a fifty-two week low of $5.26 and a fifty-two week high of $6.97.

BioSyent Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, March 15th. Investors of record on Thursday, February 29th were paid a $0.0332 dividend. This represents a yield of 2.08%. This is a boost from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Wednesday, February 28th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.